Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept.
about
Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Hyperthermic intracavitary nan ...... on and first proof of concept.
@en
Hyperthermic intracavitary nan ...... on and first proof of concept.
@nl
type
label
Hyperthermic intracavitary nan ...... on and first proof of concept.
@en
Hyperthermic intracavitary nan ...... on and first proof of concept.
@nl
prefLabel
Hyperthermic intracavitary nan ...... on and first proof of concept.
@en
Hyperthermic intracavitary nan ...... on and first proof of concept.
@nl
P2093
P2860
P356
P1476
Hyperthermic intracavitary nan ...... on and first proof of concept.
@en
P2093
Alexander Bellendorf
Jürgen Zieren
Mehdi Ouaissi
Michael Stintz
Stephan Große
Thomas Albert Falkenstein
Urs Giger-Pabst
P2860
P304
P356
10.3762/BJNANO.8.272
P577
2017-12-18T00:00:00Z